Eli Lilly CEO David Ricks during an interview at the Economic Club of New York (Jeenah Moon/Bloomberg via Getty Images)
March 13, 2024 10:15 AM EDTUpdated 02:28 PM
Pharma

Eli Lil­ly CEO David Ricks talks Chi­na, AI, and phar­ma's next 'gold­en er­a' af­ter obe­si­ty

Andrew Dunn

Senior Biopharma Correspondent

NEW YORK — Eli Lil­ly CEO David Ricks shared his view from the phar­ma in­dus­try’s peak in an hour­long con­ver­sa­tion Tues­day with the Eco­nom­ic Club of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

A service from the Financial Times